Glaukos (GKOS) FCF Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 943.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -2,196.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -20.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,679.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -461.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 417.00 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 4,003.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,003.00 |
| Dec 31, 2025 | -2,332.00 |
| Sep 30, 2025 | 4,700.00 |
| Jun 30, 2025 | 2,237.00 |
| Mar 31, 2025 | -2,252.00 |
| Dec 31, 2024 | 6,737.00 |
| Sep 30, 2024 | -7,043.00 |
| Jun 30, 2024 | 71.00 |
| Mar 31, 2024 | -4,117.00 |
| Dec 31, 2023 | -2,223.00 |
| Sep 30, 2023 | 1,841.00 |
| Jun 30, 2023 | 2,593.00 |
| Mar 31, 2023 | -2,589.00 |
| Dec 31, 2022 | 2,799.00 |
| Sep 30, 2022 | -3,885.00 |
| Jun 30, 2022 | -3,780.00 |
| Mar 31, 2022 | 550.00 |
| Dec 31, 2021 | -8,618.00 |
| Sep 30, 2021 | 5,073.00 |
| Jun 30, 2021 | -2,926.00 |
| Mar 31, 2021 | 1,967.00 |
| Dec 31, 2020 | -1,391.00 |
| Sep 30, 2020 | -2,814.00 |
| Jun 30, 2020 | -5,052.00 |
| Mar 31, 2020 | -2,945.00 |
| Dec 31, 2019 | -1,190.00 |
| Sep 30, 2019 | -991.00 |
| Jun 30, 2019 | -1,013.00 |
| Mar 31, 2019 | 487.00 |
| Dec 31, 2018 | 2,231.00 |
| Sep 30, 2018 | 1,217.00 |
| Jun 30, 2018 | 1,182.00 |
| Mar 31, 2018 | -1,214.00 |
| Dec 31, 2017 | 3,808.00 |
| Sep 30, 2017 | 1,742.00 |
| Jun 30, 2017 | 908.00 |